ArticleJournal of the Pediatric Infectious Diseases Society2026
Safety and Pharmacokinetics of Nirsevimab in Japanese Infants: Primary Analysis of the Open-Label JUBILUS Trial.
Masaaki Mori et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.